ATLAS fair value
ATLAS has no fair value for this stock today.
Beijing Centergate Technologies stock price today, ATLAS forecast and fair value
Healthcare · Medical Instruments & Supplies · Shenzhen Stock Exchange · China
Prices as of Oct 27, 2026 · CNY
ATLAS has no fair value for this stock today.
48%
that it ends higher than today in 21 sessions
ATLAS's own quantitative analysis, all in one place.
Plans from €3.99 a month.
ATLAS's model gives Beijing Centergate Technologies a 48% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between CN¥3.55 and CN¥4.26; in 9 out of 10, between CN¥3.02 and CN¥5.00. Estimated annual volatility is 56%.
ATLAS does not publish a fair value for 000931.SHE right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks 000931.SHE has traded between CN¥3.76 and CN¥5.96. Today it is 34.4% below that high and 4% above its low.
Its beta is 0.31: it tends to move less than the market.
Beijing Centergate Technologies (holding) Co., Ltd. engages in the production and sale of topical reagents, tablets, injections in China.
Want to see everything about Beijing Centergate Technologies?
Get started →Plans from €3.99 a month.
Other companies in the same line of business:
Beijing Centergate Technologies (holding) Co., Ltd. engages in the production and sale of topical reagents, tablets, injections in China.
48%: close to a coin flip. In half of the simulated outcomes, 000931.SHE ends the month between CN¥3.55 and CN¥4.26.
Beijing Centergate Technologies's market capitalization is CN¥3.3B. We do not show a P/E because it has no positive earnings to base one on.
Yes. 000931.SHE's current dividend yield is 0.46% at today's price (CN¥3.91).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy